ere’s what we’re looking out for this week in the worlds of pharma and biotech:

Ding, ding, ding! Nasdaq’s biotech index gets a makeover

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.